Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-25
    E.g., 2018-06-25

Articles

Pages

7608 items
12:20 PM, Jun 22, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Eidos raises $106M in IPO priced at top of range

Eidos Therapeutics Inc. (NASDAQ:EIDX) added $6.12 (36%) to $23.12 June 20 after raising $106.3 million through the sale of 6.3 million shares at $17 in an IPO underwritten by J.P. Morgan, BofA Merrill Lynch and...
12:15 PM, Jun 22, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Calliditas raises over $70M in Swedish IPO

Renal disease company Calliditas Therapeutics AB (SSE:CALTX) raised SEK650 million ($73.4 million) on June 15 through the sale of 14 million shares at SEK45 in an IPO on NASDAQ Stockholm. The company expects to begin...
12:15 PM, Jun 22, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

IPO roundup: Avrobio, Aptinyx, Magenta, Kezar, Xeris

Five biopharmas priced IPOs late on June 20, raising a total of more than $460 million. Four of the five upsized their offerings to sell more shares than anticipated; one of those, Avrobio, also priced...
12:03 PM, Jun 22, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

ObsEva raises $73M follow-on

Reproductive health company ObsEva S.A. (NASDAQ:OBSV) raised $73.1 million through the sale of 4.8 million shares at $15.39 in a follow-on underwritten by J.P. Morgan, Credit Suisse Securities (USA), Jefferies, Wedbush Securities and H.C. Wainwright....
12:03 PM, Jun 22, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Syncona leads Freeline's £88M series B

Freeline Therapeutics Ltd. (London, U.K.) raised £88.4 million ($116.9 million) on June 19 in a series B round which included £85 million from lead investor Syncona Ltd. (LSE:SYNC). Fellow founding investor UCL Technology Fund also...
12:02 PM, Jun 22, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Aminex raises $10M, starts Phase I cancer trial

Aminex Therapeutics Inc. (Seattle, Wash.) raised $10 million on June 20 in an untranched series B round. The company declined to name its investors. The company also said it dosed the first patient in a Phase...
12:02 PM, Jun 22, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Verrica shares jump after $75M IPO

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) added $2.50 (17%) to $17.50 in its first day of trading June 15 after the dermatology company raised $75 million through the sale of 5 million shares at $15 in an...
12:01 PM, Jun 22, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Oncology play iTeos raises $75M, outlines clinical plans

iTeos Therapeutics S.A. (Gosselies, Belgium) raised $75 million on June 19 in a series B round led by MPM Capital. Also participating in the round were HBM Partners, 6 Dimensions Capital, Curative Ventures and SFPI as...
12:01 PM, Jun 22, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Galmed raises $75M follow-on

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) raised $75 million through the sale of 5 million shares at $15 in a follow-on underwritten by Stifel, SunTrust Robinson Humphrey, Cantor Fitzgerald, Raymond James, Roth Capital Partners, Maxim Group and...
12:01 PM, Jun 22, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Rhythm raises $151.4M in follow-on

Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) raised $151.4 million on June 20 through the sale of 5.7 million shares at $26.42 in a follow-on underwritten by Morgan Stanley, BofA Merrill Lynch, Cowen and Needham. The price is...

Pages